You've changed. And your care plan should too.

An international team, led by Paul R. Fortin of Université Laval, has just identified three markers that would allow for establishing, right at the time of diagnosis, the risk of a lupus ...

There are a few to keep in mind.

The Lupus Foundation of America has partnered with Carebox, the leading software platform for clinical trial patient recruitment, to launch the Lupus Clinical Trial Finder, a free platform available ...

It's long been known that money woes tend to worsen health outcomes in people with chronic diseases. The demographics of ...

NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.

We were joined experts who shared expert insights, practical tips, and personal experiences to empower patients to build ...

Today, the Lupus Research Alliance, the world's largest private funder of lupus research, announced the 2025 Global Team ...

The treatment has been approved for NHS use, offering new hope to the nearly 12,000 people in England living with lupus ...

Roche's Gazyvaro, a drug that can restore kidney function in people living with lupus nephritis, has been cleared for use by ...

Investigators compared the risk of cancer onset in patients with lupus nephritis treated with calcineurin inhibitors vs ...

Investigators studied expression of type I interferons, key pathogenic drivers in systemic lupus erythematosus and lupus nephritis.